Rheumatoid Arthritis Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB504246733

Publication Date:

April 29, 2024

Pages:

116

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease.
The global market for Rheumatoid Arthritis Testing was estimated to be worth US$ 2008.4 million in 2023 and is forecast to a readjusted size of US$ 3487 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030
The top five players of rheumatoid arthritis testing in the world include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, and Werfen, with a total market share of more than 57%, of which the largest manufacturer is F. Hoffmann -La Roche, with over 16% market share. China is the global most important consumer market for rheumatoid arthritis testing, with a market share of about 46%. In terms of type, the market share of serological tests is over 50%. In the application field, the market share of hospitals and clinics is about 60%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rheumatoid Arthritis Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Rheumatoid Arthritis Testing by region & country, by Type, and by Application.
The Rheumatoid Arthritis Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis Testing.
Market Segmentation
By Company
Abbott Laboratories
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthineers
Augurex Life Sciences
Svar Life Science AB
Aviva Systems Biology
Bio-Rad Laboratories
Thermo Fisher Scientific
Microdrop
Werfen
Axis-Shield
Segment by Type:
Serological Tests
Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
Imaging Tests
Others
Segment by Application
Hospitals and Clinics
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Rheumatoid Arthritis Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Rheumatoid Arthritis Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Rheumatoid Arthritis Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Rheumatoid Arthritis Testing Product Introduction
1.2 Global Rheumatoid Arthritis Testing Market Size Forecast
1.3 Rheumatoid Arthritis Testing Market Trends & Drivers
1.3.1 Rheumatoid Arthritis Testing Industry Trends
1.3.2 Rheumatoid Arthritis Testing Market Drivers & Opportunity
1.3.3 Rheumatoid Arthritis Testing Market Challenges
1.3.4 Rheumatoid Arthritis Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Rheumatoid Arthritis Testing Players Revenue Ranking (2023)
2.2 Global Rheumatoid Arthritis Testing Revenue by Company (2019-2024)
2.3 Key Companies Rheumatoid Arthritis Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Rheumatoid Arthritis Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Rheumatoid Arthritis Testing
2.6 Rheumatoid Arthritis Testing Market Competitive Analysis
2.6.1 Rheumatoid Arthritis Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Rheumatoid Arthritis Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Serological Tests
3.1.2 Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
3.1.3 Imaging Tests
3.1.4 Others
3.2 Global Rheumatoid Arthritis Testing Sales Value by Type
3.2.1 Global Rheumatoid Arthritis Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Rheumatoid Arthritis Testing Sales Value, by Type (2019-2030)
3.2.3 Global Rheumatoid Arthritis Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Diagnostic Centers
4.1.3 Others
4.2 Global Rheumatoid Arthritis Testing Sales Value by Application
4.2.1 Global Rheumatoid Arthritis Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Rheumatoid Arthritis Testing Sales Value, by Application (2019-2030)
4.2.3 Global Rheumatoid Arthritis Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Rheumatoid Arthritis Testing Sales Value by Region
5.1.1 Global Rheumatoid Arthritis Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Rheumatoid Arthritis Testing Sales Value by Region (2019-2024)
5.1.3 Global Rheumatoid Arthritis Testing Sales Value by Region (2025-2030)
5.1.4 Global Rheumatoid Arthritis Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Rheumatoid Arthritis Testing Sales Value, 2019-2030
5.2.2 North America Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Rheumatoid Arthritis Testing Sales Value, 2019-2030
5.3.2 Europe Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Rheumatoid Arthritis Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Rheumatoid Arthritis Testing Sales Value, 2019-2030
5.5.2 South America Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Rheumatoid Arthritis Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Rheumatoid Arthritis Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Rheumatoid Arthritis Testing Sales Value
6.3 United States
6.3.1 United States Rheumatoid Arthritis Testing Sales Value, 2019-2030
6.3.2 United States Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Rheumatoid Arthritis Testing Sales Value, 2019-2030
6.4.2 Europe Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Rheumatoid Arthritis Testing Sales Value, 2019-2030
6.5.2 China Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Rheumatoid Arthritis Testing Sales Value, 2019-2030
6.6.2 Japan Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Rheumatoid Arthritis Testing Sales Value, 2019-2030
6.7.2 South Korea Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Rheumatoid Arthritis Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Rheumatoid Arthritis Testing Sales Value, 2019-2030
6.9.2 India Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Rheumatoid Arthritis Testing Products, Services and Solutions
7.1.4 Abbott Laboratories Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Profile
7.2.2 F. Hoffmann-La Roche Main Business
7.2.3 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Products, Services and Solutions
7.2.4 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.2.5 F. Hoffmann-La Roche Recent Developments
7.3 Beckman Coulter
7.3.1 Beckman Coulter Profile
7.3.2 Beckman Coulter Main Business
7.3.3 Beckman Coulter Rheumatoid Arthritis Testing Products, Services and Solutions
7.3.4 Beckman Coulter Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Siemens Healthineers Recent Developments
7.4 Siemens Healthineers
7.4.1 Siemens Healthineers Profile
7.4.2 Siemens Healthineers Main Business
7.4.3 Siemens Healthineers Rheumatoid Arthritis Testing Products, Services and Solutions
7.4.4 Siemens Healthineers Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Siemens Healthineers Recent Developments
7.5 Augurex Life Sciences
7.5.1 Augurex Life Sciences Profile
7.5.2 Augurex Life Sciences Main Business
7.5.3 Augurex Life Sciences Rheumatoid Arthritis Testing Products, Services and Solutions
7.5.4 Augurex Life Sciences Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Augurex Life Sciences Recent Developments
7.6 Svar Life Science AB
7.6.1 Svar Life Science AB Profile
7.6.2 Svar Life Science AB Main Business
7.6.3 Svar Life Science AB Rheumatoid Arthritis Testing Products, Services and Solutions
7.6.4 Svar Life Science AB Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Svar Life Science AB Recent Developments
7.7 Aviva Systems Biology
7.7.1 Aviva Systems Biology Profile
7.7.2 Aviva Systems Biology Main Business
7.7.3 Aviva Systems Biology Rheumatoid Arthritis Testing Products, Services and Solutions
7.7.4 Aviva Systems Biology Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Aviva Systems Biology Recent Developments
7.8 Bio-Rad Laboratories
7.8.1 Bio-Rad Laboratories Profile
7.8.2 Bio-Rad Laboratories Main Business
7.8.3 Bio-Rad Laboratories Rheumatoid Arthritis Testing Products, Services and Solutions
7.8.4 Bio-Rad Laboratories Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Bio-Rad Laboratories Recent Developments
7.9 Thermo Fisher Scientific
7.9.1 Thermo Fisher Scientific Profile
7.9.2 Thermo Fisher Scientific Main Business
7.9.3 Thermo Fisher Scientific Rheumatoid Arthritis Testing Products, Services and Solutions
7.9.4 Thermo Fisher Scientific Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Thermo Fisher Scientific Recent Developments
7.10 Microdrop
7.10.1 Microdrop Profile
7.10.2 Microdrop Main Business
7.10.3 Microdrop Rheumatoid Arthritis Testing Products, Services and Solutions
7.10.4 Microdrop Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Microdrop Recent Developments
7.11 Werfen
7.11.1 Werfen Profile
7.11.2 Werfen Main Business
7.11.3 Werfen Rheumatoid Arthritis Testing Products, Services and Solutions
7.11.4 Werfen Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.11.5 Werfen Recent Developments
7.12 Axis-Shield
7.12.1 Axis-Shield Profile
7.12.2 Axis-Shield Main Business
7.12.3 Axis-Shield Rheumatoid Arthritis Testing Products, Services and Solutions
7.12.4 Axis-Shield Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
7.12.5 Axis-Shield Recent Developments
8 Industry Chain Analysis
8.1 Rheumatoid Arthritis Testing Industrial Chain
8.2 Rheumatoid Arthritis Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Rheumatoid Arthritis Testing Sales Model
8.5.2 Sales Channel
8.5.3 Rheumatoid Arthritis Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abbott Laboratories
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthineers
Augurex Life Sciences
Svar Life Science AB
Aviva Systems Biology
Bio-Rad Laboratories
Thermo Fisher Scientific
Microdrop
Werfen
Axis-Shield

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂